Fexofenadine
Product Images NDC 55648-987

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Fexofenadine (NDC 55648-987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Fexofenatabotc Figure 01)

Carton (Fexofenatabotc Figure 01)
Packaging label for Children's Fexofenadine HCl Tablets, USP 30 mg, an antihistamine allergy medication by Wockhardt Limited. The label indicates a 6-tablet count, each tablet containing 30 mg. It highlights 12-hour relief for children 6 years and older, listing relief of sneezing, runny nose, itchy watery eyes, and itchy nose or throat.*
FDA Label Image

Blister (Fexofenatabotc Figure 02)

Blister (Fexofenatabotc Figure 02)
Fexofenadine HCl Tablet, USP 60 mg packaging label distributed by Wockhardt USA LLC, Parsippany, NJ. The label indicates a 12 Hour allergy medication with multiple identical dosing cards sealed with peel and tear instructions. NDC 64679-982-08 is visible on each label segment.*
FDA Label Image

Carton (Fexofenatabotc Figure 03)

Carton (Fexofenatabotc Figure 03)
Fexofenadine HCl Tablets, USP 60 mg packaging label produced by Wockhardt Limited. The label indicates the tablets are antihistamine allergy relief for indoor and outdoor allergies, providing 12-hour relief of sneezing, runny nose, itchy watery eyes, and itchy nose or throat. The package contains 12 tablets, each 60 mg. The label includes dosage directions, warnings, inactive ingredients, and a barcode.*
FDA Label Image

Label (Fexofenatabotc Figure 04)

Label (Fexofenatabotc Figure 04)
Drug facts panel for Fexofenadine HCl 180 mg tablets, USP, manufactured by Wockhardt Limited. It includes active ingredient information, uses, warnings, directions for adults and children, inactive ingredients list, storage instructions, and contact information for questions or comments. The label emphasizes allergy relief for indoor and outdoor allergies, dosage guidance, and precautionary advice for specific populations.*
FDA Label Image

Carton (Fexofenatabotc Figure 05)

Carton (Fexofenatabotc Figure 05)
Fexofenadine HCl Tablets, USP packaging label by Wockhardt Limited, featuring 180 mg strength oral tablets. The label highlights its use for allergy relief, providing 24-hour relief for indoor and outdoor allergies. The carton contains 30 tablets and includes directions, warnings, inactive ingredients, and safety seal information. The label shows the Wockhardt logo and distributor details.*
FDA Label Image

Label (Fexofenatabotc Figure 06)

Label (Fexofenatabotc Figure 06)
Drug facts panel for Fexofenadine HCl Tablets USP 180 mg, a non-drowsy antihistamine for allergy relief. The panel lists active ingredient strength, uses for symptoms like runny nose and itchy eyes, warnings including kidney disease and pregnancy, directions for adults and children, storage instructions, and inactive ingredients. Labeler is Wockhardt Limited.*
FDA Label Image

Carton (Fexofenatabotc Figure 07)

Carton (Fexofenatabotc Figure 07)
Fexofenadine HCl Tablets USP 180 mg oral antihistamine tablets for allergy relief, packaged in a carton containing 45 tablets. The label states the product is non-drowsy and intended for indoor and outdoor allergy relief. Labeler information includes Wockhardt Limited as manufacturer and Wockhardt USA LLC as distributor. The package includes directions, warnings, inactive ingredients, and storage instructions.*
FDA Label Image

Carton (Fexofenatabotc Figure 08)

Carton (Fexofenatabotc Figure 08)
Fexofenadine HCl Tablets USP allergy medication in a 180 mg strength. The package contains 90 tablets divided into 2 bottles of 45 tablets each. Labeled for indoor and outdoor allergy relief, produced and distributed by Wockhardt Limited. The label includes directions, active and inactive ingredients, warnings, and a barcode.*
FDA Label Image

Blister (Fexofenatabotc Figure 09)

Blister (Fexofenatabotc Figure 09)
Label for Children's Fexofenadine HCl Tablet USP 30 mg, 12 Hour allergy medication distributed by Wockhardt USA LLC, Parsippany, NJ. Multiple identical labels arranged in two columns and three rows, each with NDC 64679-744-08, highlighting the 30 mg strength and 12-hour duration.*
FDA Label Image

Blister (Fexofenatabotc Figure 10)

Blister (Fexofenatabotc Figure 10)
Label panel for Fexofenadine HCl Tablet, USP 180 mg, highlighting a 24 Hour allergy relief formulation. Distributed by Wockhardt USA LLC, Parsippany, NJ. The label includes NDC 64679-987-09, space for lot number and expiration date, and tear/peel instructions for individual sections.*
FDA Label Image

Carton (Fexofenatabotc Figure 11)

Carton (Fexofenatabotc Figure 11)
Fexofenadine HCl Tablets, USP 180 mg allergy medication packaging label by Wockhardt Limited. The label highlights 24-hour relief for indoor and outdoor allergies and lists active ingredient as Fexofenadine HCl 180 mg. It contains 5 tablets per package. The label includes warnings, directions for use by age group, inactive ingredients, and a customer service phone number.*
FDA Label Image

Carton (Fexofenatabotc Figure 12)

Carton (Fexofenatabotc Figure 12)
Fexofenadine HCl Tablets, USP 180 mg allergy relief 24-hour package label by Wockhardt Limited. The carton states 15 tablets per package and highlights non-drowsy antihistamine use for indoor and outdoor allergies. It includes Drug Facts, warnings, directions, inactive ingredients, and a toll-free contact. The label features a barcode and manufacturer details from Mumbai, India, and distribution in New Jersey, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.